Showing results (31-40 of 481) with videos related to
Sort By:
Pageof 49
ACS Applied Materials & Interfaces|April 5, 2018
Simultaneous Printing of Two Inks by Contact LithographyDavid Moore, Ravi F SarafEnvironmental Monitoring and Assessment|August 13, 2008
Soil solution and sugar maple response to NH(4)NO (3) additions in a base-poor northern hardwood forest of Québec, CanadaJean-David Moore, Daniel HouleGlobal Change Biology|September 18, 2014
Questioning the use of an amphibian colour morph as an indicator of climate changeJean-David Moore, Martin OuelletInternational Journal of Occupational and Environmental Health|February 11, 2005
Assessing the health implications for healthcare workers of regulatory changes eliminating locally developed occupational exposure limits in favor of TLVs: an evidence-based bipartite approachPhilip Bigelow, David Moore, Annalee YassiForensic Science International. Genetics|June 12, 2016
Description of artefacts in the PowerPlex Y23(®) system associated with excessive quantities of background female DNADavid Moore, Tim Clayton, Jim ThomsonSystematic Reviews|August 17, 2014
Family-based interventions for substance misuse: a systematic review of systematic reviews--protocolYasmin Akram, Alex Copello, David MooreSociology of Health & Illness|September 22, 2019
Enacting alcohol realities: gendering practices in Australian studies on 'alcohol-related presentations' to emergency departmentsDavid Moore, Helen Keane, Duane DuncanJournal of Biotechnology|October 6, 2012
Genetically programmed superparamagnetic behavior of mammalian cellsTaeuk Kim, David Moore, Martin FusseneggerHealth Sociology Review : the Journal of the Health Section of the Australian Sociological Association|January 29, 2024
Masculine enhancement as health or pathology: gender and optimisation discourses in health promotion materials on performance and image-enhancing drugs (PIEDs)Gemma Nourse, Suzanne Fraser, David MoorePharmacoeconomics|July 21, 2011
Cautions regarding the fitting and interpretation of survival curves: examples from NICE single technology appraisals of drugs for cancerMartin Connock, Chris Hyde, David MoorePageof 49